<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2023</study_start_year><data_sharing_plan>IPD Sharing (as of July 2023): No</data_sharing_plan><condition>Neoplasm Metastasis</condition><condition>Liver Metastasis Colon Cancer</condition><condition>Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><disease>Neoplasm Metastasis</disease><disease>Liver Metastasis Colon Cancer</disease><disease>Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/11959</full_dataset_link><location>Canada</location><study_start_month>9</study_start_month><repository>ECRIN MDR</repository><study_status>Not yet recruiting</study_status></additional><is_claimable>false</is_claimable><name>SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases</name><description>The purpose of this study is to prospectively evaluate the feasibility of SBRT for the management of synchronous oligo metastatic liver metastases from colorectal cancers.</description><dates><creation>2023-09-15</creation></dates><accession>11959</accession><cross_references><ClinicalTrials___gov>NCT05775146</ClinicalTrials___gov></cross_references></HashMap>